September 2025
1. BRUMBAUGH B, Westmeijer M, Thompson B, Holt A, et al
   Risk of Cutaneous T-cell Lymphoma in Patients with Autoimmune Diseases.
   J Am Acad Dermatol. 2025 Sep 11:S0190-9622(25)02793.
   

   >> Share

   
   August 2025
2. PANG Y, Thomas ZO, Ayanruoh LD, Enriquez GH, et al
   Skin microbiota differs between Black and White patients with cutaneous T-cell lymphoma.
   J Am Acad Dermatol. 2025 Aug 22:S0190-9622(25)02675.
   

   >> Share

   
   
3. NGUYEN AJ, Link JL, Johnson EF, Todd A, et al
   Assessing the utility of incorporation of clinical and histopathologic features for risk stratification in plaque-stage folliculotropic mycosis fungoides: A retrospective validation study.
   J Am Acad Dermatol. 2025;93:398-405.
   

   >> Share

   
   
4. GOYAL A, O'Leary D, Dabaja B, Weng WK, et al
   ASTCT and USCLC clinical practice recommendations for allogeneic stem cell transplant in mycosis fungoides and Sezary syndrome.
   J Am Acad Dermatol. 2025;93:387-397.
   

   >> Share

   
   April 2025
5. JIN Y
   Considerations on the Potential Link Between Dupilumab and Cutaneous T-cell Lymphoma in Atopic Dermatitis.
   J Am Acad Dermatol. 2025 Apr 4:S0190-9622(25)00563.
   

   >> Share

   
   February 2025
6. ZOU M, Zhan K, Zhang Y, Li L, et al
   A systematic review of paraneoplastic pemphigus and paraneoplastic autoimmune multiorgan syndrome: Clinical features and prognostic factors.
   J Am Acad Dermatol. 2025;92:307-310.
   

   >> Share

   
   
7. LIAO V, Lavin L, Pulitzer MP, Stuver R, et al
   Diagnosis of cutaneous T-cell lymphoma following exposure to biologic agents for atopic dermatitis: A retrospective cohort study from a single tertiary cancer center.
   J Am Acad Dermatol. 2025 Feb 1:S0190-9622(25)00188.
   

   >> Share

   
   December 2024
8. ACCETTA J, Gioe R, Rogers L, Chastain W, et al
   Cutaneous T cell lymphoma arising in patients treated with dupilumab: a case series of 18 patients.
   J Am Acad Dermatol. 2024 Dec 14:S0190-9622(24)03371.
   

   >> Share

   
   
9. ZVULUNOV A, Neale H, Stern J, Santaguida P, et al
   Approach to Mycosis Fungoides in children: Consensus-based recommendations.
   J Am Acad Dermatol. 2024;91:1078-1085.
   

   >> Share

   
   September 2024
10. NGUYEN TV, Marcus AF, Sinnott SJ, Coleman A, et al
    Commentary: Response to "Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: a retrospective cohort study".
    J Am Acad Dermatol. 2024 Sep 30:S0190-9622(24)02901.
    

    >> Share

    
    
11. CHEN C, Adeuyan O, Gordon ER, Schreidah CM, et al
    Impact of Fitzpatrick Skin Type on Narrowband UV-B Therapy Outcomes in Cutaneous T-cell Lymphoma: A Retrospective Analysis.
    J Am Acad Dermatol. 2024 Sep 19:S0190-9622(24)02866.
    

    >> Share

    
    
12. NEUBAUER ZJK, Brunner PM, Geskin LJ, Guttman E, et al
    Decoupling the Association of Dupilumab with Cutaneous T-Cell Lymphoma Reply to "Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: A retrospective cohort study.".
    J Am Acad Dermatol. 2024 Sep 7:S0190-9622(24)02812.
    

    >> Share

    
    August 2024
13. HASAN I, Zinn Z
    Response to Flynn et al. "Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: a retrospective cohort study.".
    J Am Acad Dermatol. 2024 Aug 27:S0190-9622(24)02727.
    

    >> Share

    
    
14. CHO YT, Chu CY
    Comments on "dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T-cell lymphoma: a retrospective cohort study".
    J Am Acad Dermatol. 2024 Aug 24:S0190-9622(24)02739.
    

    >> Share

    
    
15. FLYNN E, Leonard N, Svoboda R
    Response to Hasan et al.'s "Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: a retrospective cohort study.".
    J Am Acad Dermatol. 2024 Aug 23:S0190-9622(24)02726.
    

    >> Share

    
    
16. KRIDIN K, Ludwig RJ
    Reply to: "Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: A retrospective cohort study".
    J Am Acad Dermatol. 2024 Aug 6:S0190-9622(24)02574.
    

    >> Share

    
    
17. CHEN TL, Ma SH
    Comments on the risk of cutaneous T cell lymphoma among patients with atopic dermatitis receiving dupilumab.
    J Am Acad Dermatol. 2024 Aug 6:S0190-9622(24)02573.
    

    >> Share

    
    July 2024
18. WU KJ, Wei KC
    Response to Hasan et al.'s "Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: a retrospective cohort study.".
    J Am Acad Dermatol. 2024 Jul 19:S0190-9622(24)02496.
    

    >> Share

    
    
19. FRIEDMAN A
    JAAD Game Changers: "Guidelines for phototherapy of mycosis fungoides and Sezary syndrome: A consensus statement of the United States Cutaneous Lymphoma Consortium".
    J Am Acad Dermatol. 2024 Jul 17:S0190-9622(24)02503.
    

    >> Share

    
    
20. BRUMBAUGH BJ, Thompson BB, Holt A, Ebriani J, et al
    Delays in Diagnosis in Cutaneous T Cell Lymphoma: A Retrospective Study on Clinical Course and Time to Death.
    J Am Acad Dermatol. 2024 Jul 11:S0190-9622(24)01054.
    

    >> Share

    
    
21. SHIH PC, Wei JCC
    Response to Hasan et al.'s "Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: a retrospective cohort study.".
    J Am Acad Dermatol. 2024 Jul 11:S0190-9622(24)01041.
    

    >> Share

    
    
22. HASAN I, Zinn Z
    Response to Shih et al. "Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: a retrospective cohort study.".
    J Am Acad Dermatol. 2024 Jul 10:S0190-9622(24)01046.
    

    >> Share

    
    
23. SAMIE F
    JAAD Game Changer: Photodynamic therapy with methyl-aminolevulinic acid for paucilesional mycosis fungoides: A prospective open study and review of the literature.
    J Am Acad Dermatol. 2024;91:42.
    

    >> Share

    
    April 2024
24. HASAN I, Parsons L, Duran S, Zinn Z, et al
    Dupilumab therapy for atopic dermatitis is associated with increased risk of cutaneous T cell lymphoma: a retrospective cohort study.
    J Am Acad Dermatol. 2024 Apr 6:S0190-9622(24)00566.
    

    >> Share

    
    
25. POWERS CM, Piontkowski AJ, Orloff J, Pulsinelli J, et al
    Risk of lymphoma in patients with atopic dermatitis: A case-control study in the All of Us database.
    J Am Acad Dermatol. 2024 Apr 4:S0190-9622(24)00554.
    

    >> Share

    
    March 2024
26. BANNER L, Rohan TZ, Zachian R, Gross T, et al
    Increased incidence of thyroid, renal, lung, melanoma, bladder, and prostate cancers after diagnosis of primary cutaneous B-cell lymphoma: A SEER database analysis.
    J Am Acad Dermatol. 2024 Mar 19:S0190-9622(24)00505.
    

    >> Share

    
    
27. CHEN J, Martinez A, Shinohara MM
    Risk of Systemic Lymphoma in Patients with Cutaneous CD30+ Lymphoproliferative Disorders: A Single Center Retrospective Cohort Analysis.
    J Am Acad Dermatol. 2024 Mar 13:S0190-9622(24)00489.
    

    >> Share

    
    
28. DIAZ MJ, Haq Z, Tran JT, Abdi P, et al
    Psoriasis and non-Hodgkin's lymphoma in a diverse sample of U.S. adults: a propensity matched case-control study.
    J Am Acad Dermatol. 2024 Mar 5:S0190-9622(24)00440.
    

    >> Share

    
    February 2024
29. OLSEN EA, Hodak E, Geskin L, Scarisbrick J, et al
    Bridging the specialty gap: Update on primary cutaneous lymphomas.
    J Am Acad Dermatol. 2024;90:257-260.
    

    >> Share

    
    
30. HOOPER MJ, Veon FL, Enriquez GL, Nguyen M, et al
    Reply to Wu et al's US SEER analysis of sepsis in Black patients with CTCL.
    J Am Acad Dermatol. 2024;90:e79.
    

    >> Share

    
    January 2024
31. PATTERSON A
    JAAD Game Changer: "Early clinical manifestations of Sezary syndrome: A multicenter retrospective cohort study".
    J Am Acad Dermatol. 2024;90:121.
    

    >> Share

    
    December 2023
32. NOCCO SE, Ewalt MD, Moy AP, Lewis NE, et al
    TRBC1 immunohistochemistry distinguishes cutaneous T-cell lymphoma from inflammatory dermatitis: a retrospective analysis of 39 cases.
    J Am Acad Dermatol. 2023 Dec 5:S0190-9622(23)03269.
    

    >> Share

    
    October 2023
33. WU Y, Kang K, Sun X, Niu T, et al
    Increased risk of sepsis-caused death in Black patients with primary cutaneous T-cell lymphoma and Burkitt lymphoma: A population study of the US SEER registry.
    J Am Acad Dermatol. 2023 Oct 4:S0190-9622(23)02886.
    

    >> Share

    
    September 2023
34. XIANG DH, Perlman KL, Brumbaugh B, Reardon RM, et al
    Prevalence of Autoimmune Diseases in Cutaneous B-Cell Lymphoma: A Retrospective Cross Sectional Analysis.
    J Am Acad Dermatol. 2023 Sep 18:S0190-9622(23)02829.
    

    >> Share

    
    

Free Medical Abstracts
Privacy Policy
Sponsors
Share